PharmaTech LLC Issues Voluntary Nationwide Recall Due to Potential Risk of Product Contamination
PharmaTech, LLC of Davie, FL, is voluntarily recalling all liquid products from October 20, 2015 through July 15, 2016 as a precautionary measure due to a potential risk of product contamination with Burkholderia cepacia.If a product contains B. cepacia, its use could result in infections in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis. Some of these infections may be serious or even life-threatening in the at risk patient population. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 9, 2016 Category: Food Science Source Type: news

NHS cut raft of new treatments after HIV drug High Court ruling
Toddlers with cystic fibrosis, children born deaf, adults who have lost their legs, and patients with cancer were among those who will no longer have access to planned new treatments. (Source: the Mail online | Health)
Source: the Mail online | Health - August 4, 2016 Category: Consumer Health News Source Type: news

​Vertex plans to apply for approval of the drug that will replace Orkambi next year
Late Tuesday, Vertex Pharmaceuticals gave the latest sales figures for its newest drug to treat cystic fibrosis, called Orkambi, as well as a timeline for approval of the drug it hopes will replace it in a couple years. Shares of Boston-based Vertex (Nasdaq: VRTX) were trading about flat on Thursday morning after the company’s overall revenue and net income figures beat the bar set by analysts. Total revenue for the three months that ended in June was $432 million. That was made up mostly of sales… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 28, 2016 Category: Pharmaceuticals Authors: Don Seiffert Source Type: news

Boy With Cystic Fibrosis Gets Wish To Be Garbage Man During 'Best Day Ever'
One sweet boy’s dream come true involved a lot of trash ― and that’s a good thing.  Ethan Dean, who has cystic fibrosis, has always been fascinated with waste management. So on Tuesday, the 6-year-old had the opportunity to live out his dreams of becoming a garbage man for a day and helped pick up trash around Sacramento, California, thanks to the Make-A-Wish foundation.  The experience, which was documented on social media with the hashtag #EthanCleansUp, was no disappointment as the boy told KCRA that he had the “best day ever!” The boy, who rode in the garbage truck with Waste Manage...
Source: Healthy Living - The Huffington Post - July 27, 2016 Category: Consumer Health News Source Type: news

Vertex Pharma Loss Narrows as Cystic Fibrosis Drug Sales Grow
Vertex Pharmaceuticals Inc. said its second-quarter loss narrowed, as sales of its cystic fibrosis drugs continued to grow. (Source: WSJ.com: Health)
Source: WSJ.com: Health - July 27, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news

DNA sequencing uncovers latent risk for developing cystic fibrosis
All babies with a known mutation for cystic fibrosis (CF) and second mutation called the 5T allele should receive additional screening in order to better predict the risk of developing CF later in life, new research shows. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 25, 2016 Category: Science Source Type: news

DNA sequencing uncovers latent risk for developing cystic fibrosis
( Children's Hospital Los Angeles ) A study by researchers at Children's Hospital Los Angeles (CHLA), Brigham and Women's Hospital and the California Department of Public Health suggests that all babies with a known mutation for cystic fibrosis (CF) and second mutation called the 5T allele should receive additional screening in order to better predict the risk of developing CF later in life. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 25, 2016 Category: Global & Universal Source Type: news

Children 'going blind and risk dying from cancer' as doctors overlook crucial NF1 signs
Despite being more common than cystic fibrosis and being linked to a number of serious complications, the incurable condition neurofibromatosis (NF1) is not checked for in infancy. (Source: the Mail online | Health)
Source: the Mail online | Health - July 24, 2016 Category: Consumer Health News Source Type: news

DNA-modulating drug attenuates lung inflammation in mice
( JCI Journals ) In this issue of JCI Insight, Jay Kolls and colleagues at the University of Pittsburgh demonstrate that bromodomain and extraterminal domain (BET) inhibitors, a class of drugs that alter DNA architecture and change gene expression, attenuate cystic fibrosis lung inflammation. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 21, 2016 Category: Biology Source Type: news

7 Reasons Why Including Protein in Your Diet is a Must
When we think about protein, images of body builders and athletes come to mind. But protein has important health benefits for everyone, not just for sports enthusiasts eager to build muscle. To understand why this nutrient is so necessary in our diets, it's important to understand more about it. Think back to high school science class. Proteins are molecules that make sure that our bodies' organs and tissues function properly. They are also key components in our skin, eyes, hair, bones and nails. Proteins are made up of smaller molecules called amino acids. When we digest protein, the amino acids are what's left. These un...
Source: Healthy Living - The Huffington Post - July 19, 2016 Category: Consumer Health News Source Type: news

PharmaTech LLC Issues Voluntary Nationwide Recall of Diocto Liquid Distributed by Rugby Laboratories Due to Product Contamination
PharmaTech LLC of Davie, FL, the manufacturer of the Rugby®- branded product, is voluntarily recalling all lots within the expiry of Diocto Liquid, a docusate sodium solution due to a risk of product contamination with Burkholderia cepacia. Use of docusate sodium liquid contaminated with B. cepacia may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis. (Source: Food and Drug Administration)
Source: Food and Drug Administration - July 16, 2016 Category: Food Science Source Type: news

The adorable moment girl claps after giving HERSELF her cystic fibrosis medicine
Talia Coombs, from Warrington, pushes four plastic syringes filled with medication into her mouth without complaint - before clapping and asking for more. The clip has been seen by 100,000 people. (Source: the Mail online | Health)
Source: the Mail online | Health - July 13, 2016 Category: Consumer Health News Source Type: news

Personalized Medicine: The Way Forward?
This article will look at some of the strategies already available to help healthcare professionals meet individual patient needs, in the multifaceted field of personalized medicine. Personalizing drug therapy for depression Research suggests that around 50 percent of patients with depression do not respond to first-line antidepressants. What can explain this, and how can it be solved? Current treatment is often a case of trial and error. A patient may take one medication after another, often for 12 weeks or more each time, while symptoms remain the same, or worsen. A team from King's College London in the United Kingd...
Source: Healthy Living - The Huffington Post - July 6, 2016 Category: Consumer Health News Source Type: news

Cystic fibrosis sufferer claims POLE VAULTING saved his life 
When Jerry Cahill was diagnosed in New York in 1974, cystic fibrosis sufferers were not expected to live past 16. Even now, the average life expectancy of a CF sufferer is 36. Jerry is 60. (Source: the Mail online | Health)
Source: the Mail online | Health - July 4, 2016 Category: Consumer Health News Source Type: news

Breathing in a Cure: Inhalable Ibuprofen on the Horizon
Ibuprofen: You can buy it at any drug store, and it will help with that stabbing headache or sprained ankle. One of the ways it does so is by reducing inflammation, and it is this property that may also help patients with cystic fibrosis. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 2, 2016 Category: Science Source Type: news

Burden on patients: Insurance benefit design’s impact on patient access to medicines
Last week, we looked at access to medicines in health insurance exchanges for HIV/AIDS, oncology, cystic fibrosis, mental health and multiple sclerosis. The analysis by Avalere Health presents data on access to medications for chronic conditions in exchange plans. (Source: The Catalyst)
Source: The Catalyst - June 30, 2016 Category: Pharmaceuticals Tags: Access diabetes health insurance Burden on Patients Asthma Rheumatoid Arthritis exchanges Access Better Coverage ABCs of Coverage high cholesterol Policy Solutions Empower Consumers Source Type: news

Burden on patients: Insurance benefit design ’s impact on patient access to medicines
Last week, we looked at access to medicines in health insurance exchanges for HIV/AIDS , oncology , cystic fibrosis , mental health and multiple sclerosis . The analysis by Avalere Health presents data on access to medications for chronic conditions in exchange plans. (Source: The Catalyst)
Source: The Catalyst - June 30, 2016 Category: Pharmaceuticals Tags: Access diabetes health insurance Burden on Patients Asthma Rheumatoid Arthritis exchanges Access Better Coverage ABCs of Coverage high cholesterol Policy Solutions Empower Consumers Source Type: news

‘What a difference a year makes’: Catching up with liver brothers Brent and Malambo
Brent and Malambo We are honored U.S. News & World Report has named Boston Children’s Hospital the #1 pediatric hospital in the U.S. As we celebrate this honor, we’re reflecting on some of the greatest children’s stories ever told — stories of the patients and families whose lives touch ours and inspire us. Two of those patients are “liver brothers” Malambo Mazoka-Tyler and Brent Groder. Malambo and Brent are, by all standards, oceans apart. Zambian-born Malambo is nearly two. His world, one year after a life-saving, split-liver transplant, is all about walking and talking,...
Source: Thrive, Children's Hospital Boston - June 29, 2016 Category: Pediatrics Authors: Emily Williams Tags: Our Patients’ Stories biliary atresia cystic fibrosis liver failure Liver transplant Liver Transplant Program Pediatric Transplant Center (PTC) split-liver transplant Source Type: news

Pole Vaulter With Cystic Fibrosis Clears Odds For Survival
BOSTON (CBS) — Clearing the bar and the challenges of life and living with cystic fibrosis far longer than anyone thought he would, Jerry Cahill says exercise has made all the difference.  He is in Boston for the premiere of a documentary about his extraordinary life.  This pole vaulter from New York not only has beaten the odds, he’s crushed them. “I’m 60 years old today, yes,” says Cahill smiling. And that’s a remarkable feat.  Jerry was diagnosed with cystic fibrosis when he was a kid. “You build up a bacteria, the mucus gets really thick, and it st...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - June 27, 2016 Category: Consumer Health News Authors: larasalahi Tags: Health Local News Syndicated Local CBS Boston Dr. Mallika Marshall WBZ Source Type: news

[This Week in Science] Mini-guts for testing drug therapy
Author: Orla M. Smith (Source: ScienceNOW)
Source: ScienceNOW - June 23, 2016 Category: Science Authors: Orla M. Smith Tags: Cystic Fibrosis Source Type: news

Burden on patients: Access to medicines in health insurance exchange plans
Access to prescription medicines is critical to help patients manage their chronic conditions and maximize quality of life. Unfortunately, even with insurance coverage, many patients still struggle to get the medicines they need due to high out-of-pocket costs and other plan restrictions. We looked at the burden on patients with health insurance exchange coverage in 2014 and 2015. Now, we’re taking a look at 2016 coverage. (Source: The Catalyst)
Source: The Catalyst - June 23, 2016 Category: Pharmaceuticals Tags: Access Cystic Fibrosis health insurance HIV/AIDS Burden on Patients Multiple Sclerosis exchanges Mental Health Oncology Access Better Coverage ABCs of Coverage Policy Solutions Empower Consumers Source Type: news

Stem cells from human INTESTINES could help treat rare life-threatening cystic fibrosis
SCIENTISTS from the Netherlands have revealed that stem cells from intestines of cystic fibrosis patients can predict if a specific medicine will be effective for sufferers of the disease. (Source: Daily Express - Health)
Source: Daily Express - Health - June 23, 2016 Category: Consumer Health News Source Type: news

NICE issues Final Appraisal Determination for Vertex’s Orkambi to treat cystic fibrosis
The National Institute for Health and Care Excellence (NICE) in the UK has issued a Final Appraisal Determination (FAD) for Massachusetts-based pharmaceutical company Vertex’s Orkambi (lumacaftor / ivacaftor), as a new therapy for treating cystic fib… (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - June 20, 2016 Category: Pharmaceuticals Source Type: news

THOUSANDS with life-threatening cystic fibrosis will miss out on ‘breakthrough’ treatment
ALMOST 3,000 people with cystic fibrosis will miss out on a ‘breakthrough’ treatment after the health watchdog turned it down for use on the NHS. (Source: Daily Express - Health)
Source: Daily Express - Health - June 17, 2016 Category: Consumer Health News Source Type: news

Cystic fibrosis drug Orkambi 'too pricey for the NHS'
The National Institute for Health and Care Excellence rejected the drug, which has been shown in clinical trials to improve lung function and respiratory symptoms in people with cystic fibrosis. (Source: the Mail online | Health)
Source: the Mail online | Health - June 17, 2016 Category: Consumer Health News Source Type: news

Cystic fibrosis sufferer Jessica Bean credits sugar-free lifestyle with saving her life
A sugar free diet has been credited with everything from extreme weight loss to healing acne. Now cystic fibrosis sufferer, Jessica Bean, 28, from Queensland claims cutting out sugar saved her life. (Source: the Mail online | Health)
Source: the Mail online | Health - June 17, 2016 Category: Consumer Health News Source Type: news

BREXIT: Is the Pharmaceutical Industry at Risk?
In general, the pharmaceutical industry has benefited from the UK being within the European Union; from centralized European drug approvals that simplify the regulatory process to research funding grants that support universities and innovation. The full impact of a potential Brexit on market access, patient access and innovation is still unknown. What impact would Brexit have on pricing? The majority of European countries use an International Reference Pricing (IRP) mechanism to establish the price of a new pharmaceutical product. While most of these countries would not be impacted directly by Brexit, countries that refer...
Source: EyeForPharma - June 17, 2016 Category: Pharmaceuticals Authors: Preeti Patel Source Type: news

Raptor Pharmaceutical Announces Presentation of New Data Analyses from a Phase 3 Study of QUINSAIR(TM) at the 39th European Cystic Fibrosis Conference
NOVATO, Calif., June 10, 2016 -- (Healthcare Sales & Marketing Network) -- Raptor Pharmaceutical Corp. (RPTP), a biopharmaceutical company developing and commercializing transformative treatments for rare diseases, today announced new data analyses of its ... BiopharmaceuticalsRaptor Pharmaceutical, QUINSAIR, Cystic Fibrosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 10, 2016 Category: Pharmaceuticals Source Type: news

The future of gene research - podcast
How does our genetic makeup help or hinder our chances in life? And as our ability to unravel DNA becomes more powerful, what are the implications?Scientists are finding ways to alter the genetic makeup of children with harmful mutations such as cystic fibrosis and muscular dystrophy. Will we soon see more complex disorders such as cancers and heart disease being tackled in this way, by altering or replacing entire groups of genes? To tackle these questions and more, Ian Sample is joined in the studio by Siddharta Mukherjee, whose new book spans the history of genetics, from Gregor Mendl’s 19th century experiments to...
Source: Guardian Unlimited Science - June 10, 2016 Category: Science Authors: Ian Sample, Siddhartha Muherjee (contributor) and Iain Chambers Tags: Science Genetics Biology Health & wellbeing Source Type: news

Medical News Today: Cystic fibrosis patients may benefit from repurposed approved drug
Study finds drug approved to treat metabolic acidosis intravenously might serve as an aerosol to reduce airway surface liquid acidity in cystic fibrosis. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 3, 2016 Category: Consumer Health News Tags: Cystic Fibrosis Source Type: news

New UK-wide study investigates the safety and effectiveness of antibiotics on babies with cystic fibrosis (CF)
The a new clinical trial, CF START, is exploring whether infants with cystic fibrosis (CF) should be prescribed a long-term antibiotic that they take twice a day, every day or if they should be treated in a more targeted manner, with antibiotics given when required. This trial funded by the NIHR and supported by the... (Source: NIHR Evaluation, Trials and Studies News)
Source: NIHR Evaluation, Trials and Studies News - May 26, 2016 Category: American Health Source Type: news

Fixing cystic fibrosis: In vitro studies show therapeutically robust correction of the most common CF gene mutation
In experiments with isolated cystic fibrosis lung cells, researchers have partially restored the lost function of those cells to therapeutic levels. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 25, 2016 Category: Science Source Type: news

Therapeutically robust correction, in vitro, of the most common cystic fibrosis mutation
(University of Alabama at Birmingham) In experiments with isolated cystic fibrosis lung cells, researchers have partially restored the lost function of those cells to therapeutic levels. The work is proof-of-concept for using a yeast genetic model to find therapeutic targets, in this case for people with the most common cystic fibrosis mutation, called deltaF508-CFTR. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 25, 2016 Category: Global & Universal Source Type: news

Stebbins, Cocohoba leading specialty drug study with Walgreens
So-called specialty drugs can represent lifesaving advances in the treatment of serious complex conditions, such as cancers, hepatitis C, rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. They can turn once routinely lethal diseases such as HIV and cystic fibrosis into manageable chronic conditions. They can address rare genetic conditions, such as hemophilia, or suppress immune rejection after organ transplants. (Source: UCSF School of Pharmacy News)
Source: UCSF School of Pharmacy News - May 24, 2016 Category: Universities & Medical Training Authors: Paula Joyce Source Type: news

The Prognosis of Cystic Fibrosis - A Clinician's Perspective
The Prognosis of Cystic Fibrosis - A Clinician's Perspective2012Post date: Tuesday, May 17, 2016 - 16:27Books and theses (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 17, 2016 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Radiological Features of Cystic Fibrosis
2012Post date: Tuesday, May 17, 2016 - 16:17Books and theses (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 17, 2016 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Nivalis starts dosing patients in second phase 2 trial of N91115 to treat CF
US-based clinical-stage pharmaceutical company Nivalis Therapeutics has dosed the first patient in a second phase 2 clinical trial of N91115 to treat cystic fibrosis (CF). (Source: Drug Development Technology)
Source: Drug Development Technology - May 17, 2016 Category: Pharmaceuticals Source Type: news

Medical News Today: Cystic fibrosis: New molecule may prolong patient survival
Scientists have discovered a new protease inhibitor with potential to improve airway hydration and mucus clearance, and thus reduce frequency of infection in cystic fibrosis. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 13, 2016 Category: Consumer Health News Tags: Cystic Fibrosis Source Type: news

Scientists develop new treatment to prolong life of those with cystic fibrosis
A new molecule has been discovered that has the potential to prolong the life of individuals with cystic fibrosis (CF). The molecule represents a possible future treatment and works by altering cellular ion channels resulting in improved airway hydration and significantly increased mucus clearance. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 12, 2016 Category: Science Source Type: news

Queen's scientists develop new treatment to prolong life of those with cystic fibrosis
(Queen's University Belfast) Scientists at Queen's University Belfast have discovered a new molecule which has the potential to prolong the life of individuals with cystic fibrosis.The molecule represents a possible future treatment and works by altering cellular ion channels resulting in improved airway hydration and significantly increased mucous clearance. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 12, 2016 Category: Global & Universal Source Type: news

Galapagos begins Phase l trial of GLPG2451 to treat cystic fibrosis
Belgium-based, clinical-stage, biotechnology company Galapagos has begun a Phase l trial of GLPG2451 potentiator to treat cystic fibrosis (CF). (Source: Drug Development Technology)
Source: Drug Development Technology - May 10, 2016 Category: Pharmaceuticals Source Type: news

When Just a Little Is Too Much: The Risks of Alcohol-Exposed Pregnancy
One of my challenges in working with patients suffering from addictive illnesses is to help increase their motivation to stick with a long-term recovery plan. This is a significant challenge for many reasons, especially because the disease of addiction affects the brain's ability to value long term recovery. The one exception to this difficulty, in many cases, is when a female patient gets pregnant. I have witnessed women who struggled for years with an addictive illness discover they are pregnant and, when the pregnancy is wanted, are able to make incredible strides in their recovery. They are often able to maintain sobri...
Source: Healthy Living - The Huffington Post - May 9, 2016 Category: Consumer Health News Source Type: news

New PhRMA Report: Medicines in development for patients with rare diseases demonstrate the promise of innovation
Today, there are 7,000 known rare diseases, or diseases that affect fewer than 200,000 people in the United States. But those suffering from the impact of these diseases have more hope today because of advances in science that promise brighter futures for American patients and families. A new report, “Medicines in Development for Rare Diseases,” offers insight into the more than 560 novel treatments currently in the biopharmaceutical pipeline for the 30 million Americans currently living with a rare disease that have few or no treatment options, including patients with multiple myeloma, cystic fibrosis, amyotr...
Source: The Catalyst - May 9, 2016 Category: Pharmaceuticals Authors: Ieva M. Augstums Tags: Medicines in Development ALS Rare Diseases Source Type: news

Newborn screening for cystic fibrosis
The benefits of newborn screening for cystic fibrosis (CF) patients has been reinforced by new research. The findings add to the increasingly overwhelming evidence in favor of newborn screening as a way to improve the quality of life for patients living with this chronic disease that is still incurable. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 5, 2016 Category: Science Source Type: news

Newborn screening test developed for rare, deadly neurological disorder
Soon after birth, a baby's blood is sampled and tested for a number of rare inherited conditions, such as cystic fibrosis and sickle cell anemia. A new study describes a novel newborn screening test for a progressive neurodegenerative disease, called Niemann-Pick type C (NPC), that typically is not diagnosed until at least age 2, after neurological symptoms have begun to develop. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 4, 2016 Category: Science Source Type: news

New Tool Measures Lung Function over the Phone
Most people in the developing world who have asthma, cystic fibrosis or other chronic lung diseases have no way to measure how well their lungs are functioning outside of a clinic or doctor visit. But many do have access to a phone, though it may be a 10-year-old flip phone or a communal village landline instead of the latest app-driven smartphone. (Source: eHealth News EU)
Source: eHealth News EU - May 4, 2016 Category: Information Technology Tags: Featured Development Research and Development Source Type: news

Newborn screening for cystic fibrosis
(McGill University Health Centre) A new study led by a team from the Research Institute of the McGill University Health Centre and Cystic Fibrosis Canada reinforces the benefits of newborn screening for cystic fibrosis (CF) patients. The findings, recently published online in the Journal of Cystic Fibrosis, add to the increasingly overwhelming evidence in favor of newborn screening as a way to improve the quality of life for patients living with this chronic disease that is still incurable. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 4, 2016 Category: Global & Universal Source Type: news

Celtaxsys starts enrolment in Europe for Phase ll trial of acebilustat to treat cystic fibrosis
Clinical stage drug development company Celtaxsys has started enrolling subjects in Europe for a global Phase ll clinical trial of its acebilustat anti-inflammatory therapy to treat people with cystic fibrosis (CF). (Source: Drug Development Technology)
Source: Drug Development Technology - May 4, 2016 Category: Pharmaceuticals Source Type: news

Recurrent viral RTIs in first 6 months linked to type 1 diabetes risk
Infections in early life associated with almost a fifth greater risk of developing diabetesRelated items from OnMedicaPregnancy raises risk of critical illness with swine fluAntibiotic fails to improve lung function in children with CFTexting can improve flu jab uptakeImprove uptake of MMR jab to meet WHO targetBabies with cystic fibrosis live longer in the EU (Source: OnMedica Latest News)
Source: OnMedica Latest News - May 4, 2016 Category: UK Health Source Type: news

What Causes Vomiting?
Discussion Regurgitation is a passive expulsion of ingested material out of the mouth. It is a normal part of digestion for ruminants such as cows and camels. Nausea is an unpleasant abdominal perception that the person may describe as feeling ill to the stomach, or feeling like he/she is going to vomit. Anorexia is frequently observed. Nausea is usually associated with decreased stomach activity and motility in the small intestine. Parasympathetic activity may be increased causing pale skin, sweating, hypersalivation and possible vasovagal syndrome (hypotension and bradycardia). Retching or dry heaves is when there are sp...
Source: PediatricEducation.org - May 2, 2016 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news